1 of 0.9% normal saline as default maintenance fluid in acutely ill patients fails to consider the increased risk of hypernatremia and volume expansion that may occur. Both complications may be potentially as damaging as the hyponatremia that the authors seek to avoid.
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To the Editor: The review by Moritz and Ayus raises certain issues that may be debated. Fluid tonicity is determined by the total concentration of osmotically active ions, and not solely sodium. Similarly, the desired composition of maintenance intravenous fluids should include not just sodium chloride but adequate dextrose and potassium to prevent starvation ketosis and hypokalemia, respectively, especially for surgical patients during prolonged fasting.
1,2 However, adding concentrated potassium chloride to isotonic saline risks misadministration 3 and renders the latter hypertonic. The sodium load with cumulative 0.9% saline infusion may compound hypervolemic risk among susceptible patients with cardiac or renal disease. The use of chloriderich solutions is also strongly associated with increased morbidity in critically ill and surgical cohorts. 4, 5 Balanced electrolyte solutions contain more physiologic chloride content and are nearly isotonic but have insufficient potassium for maintenance use. Premixed solutions with dextrose 5% and potassium chloride with varying saline content help address these dilemmas but are limited by their hypotonic tendencies. An individualized approach to maintenance-fluid selection should be based on the above considerations, bearing imperfections of all available solutions. But default maintenance with 0.9% saline is certainly not ideal. T h e ne w e ngl a nd jou r na l o f m e dicine n engl j med 374;3 nejm.org January 21, 2016 290 not mention one viable alternative -no maintenance fluid. In our medical intensive care unit, we do not routinely prescribe standing intravenous fluids and would challenge the concept of an "almost ubiquitous need for intravenous fluids in acutely ill patients." If a patient is volumedepleted and presumed to be volume-responsive, we provide fluid boluses with reevaluations before additional doses. Often, between tube feedings and intravenous medications, our patients receive liters a day of fluid without starting traditional maintenance fluid.
I agree with the authors' assertion that hypotonic fluid often leads to hyponatremia but would add that isotonic fluid (0.9% saline) may lead to hyperchloremic acidosis and may contribute to renal failure.
1,2 Furthermore, several studies now provide evidence that a positive fluid balance in critically ill patients with sepsis or the acute respiratory distress syndrome correlates with increased mortality. 3, 4 On the basis of such studies, I would advocate that not giving maintenance intravenous fluid is a viable alternative for acutely ill patients.
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To the Editor: The review by Moritz and Ayus highlights the importance of avoiding iatrogenic hyponatremia, particularly in central nervous system (CNS) disease, to avoid osmotic edema. Appropriate selection of electrolyte composition, tonicity, and the rate of administration of intravenous fluids is key to reducing the risk of potential complications. Although we agree with the general management recommendations made in this review, we disagree with the suggestion that "5% dextrose in isotonic solution" (see Fig. 2 of the article, available at NEJM.org) should be used as first-line fluid therapy for CNS disease and particularly for stroke (see Case 2 of the article).
Stress hyperglycemia is common after acute CNS injury. We argue that dextrose should be avoided in any patient with a stroke, ischemic or hemorrhagic, who is hyperglycemic because it could lead to a poor outcome. 1, 2 In addition, hyperglycemia has been consistently linked to an increased risk of hemorrhage among patients with stroke who are treated with tissue plasminogen activator. 3 We suggest that the addition of dextrose in acutely ill patients follows guidelines for glycemic control that were outlined previously in the Journal. type of intravenous fluid can result in fluid overload if administered in excessive quantities (for example, in patients with end-stage renal disease or heart failure in whom both sodium excretion and water excretion are impaired)." Isotonic fluids are otherwise incapable of producing hypernatremia or fluid overload, because a normally functioning kidney can generate free water by excreting a hypertonic urine.
1 This is a physiologic response, as we have described previously in healthy ambulatory children, 2 and this response explains why hyponatremia (rather than fluid overload) develops in patients with a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like states in response to intravenous fluids. The subclinical volume expansion associated with an excess of arginine vasopressin triggers hemodynamic regulatory mechanisms to maintain plasma volume at the expense of plasm sodium, which is in part due to a pressure-natriuresis mechanism and a secondary release of natriuretic peptides. 3 As was stated in our article, in more than 15 randomized, prospective trials involving more than 2000 patients, isotonic fluids were not associated with an increased risk of hypernatremia or fluid overload. In Table 1 and Figure 2 of our article, we outline the disease states that require special considerations in fluid management, and we provide an algorithm for adjusting the intravenous-fluid rate and composition in order to prevent fluid overload and hypernatremia.
Chua and Lief raise an additional concern regarding the high chloride concentration in 0.9% saline. After the publication of our article, a randomized study by Young et al. compared 0.9% saline with a balanced electrolyte solution in more than 2000 critically ill patients. 4 They found no significant between-group differences in complications such as acute kidney injury, a need for mechanical ventilation, electrolyte disturbances, and death. Lief questions the needs for maintenance fluids in critically ill patients owing to the risk of fluid overload. As stated in Figure 2 of our article, maintenance fluids are indicated only after the resuscitation phase of fluid therapy, and we recommend fluid restriction to 25 ml per hour for oligoanuric states in order to prevent fluid overload.
Petzold et al. correctly point out the dangers of hyperglycemia in patients with stroke. To the best of our knowledge, 5% dextrose in maintenance fluids is not associated with hyperglycemia in the absence of diabetes.
